Eli Lilly wraps $247M deal for PhII diabetes drug

John Carroll Eli Lilly is stepping in to take control of an experimental diabetes drug from Canada's Transition Therapeutics, paying $ 7 million upfront and promising up to $ ...

Investors snub Elan deals, but buyback win could scuttle hostile offer

John Carroll Elan's shareholders rejected a string of CEO Kelly Martin's deals today, but did green-light a share repurchase pact–which the biotech says will put the hex ...

Avastin Approved in Japan for Malignant Glioma

barbara.lempert Anti-Cancer Agent “Avastin®,” Obtained Approval for Additional Indication and Dosage and Administration of Malignant Glioma June 14, 2013 (Tokyo) – ...

Access To The Morning After Pill Remains An Issue: Baruch Explains

esilverman Earlier this week, the Obama administration gave up its fight to block over-the-counter access to the newer, more popular version of the morning after pill called ...

Wockhardt gets kicked in the gut again

Eric Palmer There is more financially painful news for India's Wockhardt. India has banned the sale of painkiller dextropropoxyphene, and Wockhardt's branded version, Proxyvon, ...

ACETO Names Satish Srinivasan as Rising Pharmaceuticals’ President and COO

barbara.lempert PORT WASHINGTON, N.Y., June 13, 2013 (GLOBE NEWSWIRE) — ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for ...

Glaxo’s dismissed China R&D chief fires back

Ryan McBride GlaxoSmithKline fired Jingwu Zang after allegations that the R&D shop he helmed in China published falsified data. Yet Zang has fired back in a report from The Wall ...

IBS-C Drug Constella Launched in Europe

barbara.lempert Constella® (linaclotide), the first approved prescription therapy in a new class of treatments for adults with IBS-C, is now available in Europe •   ...

Abyrx Receives FDA 510(k) Clearance for New Absorbable Hemostatic Bone Putty

barbara.lempert Abyrx Receives FDA 510(k) Clearance for New Absorbable Hemostatic Bone Putty (AHBP™) IRVINGTON, N.Y., June 12, 2013 /PRNewswire/ — Abyrx, Inc., a privately-held ...

EMD Millipore Launches PluriSTEM Human ES/iPS Medium for the Expansion of Human Embryonic and Induced Pluripotent Stem Cells

barbara.lempert •    Enables routine expansion of cells in feeder-free and serum-free conditions •    Supports less frequent feeding and cell culture time, saving time ...

Consumer Watchdog: United Healthcare Sued for Discriminating Against HIV/AIDS Patients

barbara.lempert Recent Settlement in Similar Lawsuit Allows Anthem Blue Cross Patients To “Opt-Out” of Mandatory Mail-Order Rx Drug Program SANTA MONICA, Calif., June ...

Sales upside for Sanofi’s Fluzone Quadrivalent looks strong

Eric Palmer The FDA two days ago gave its approval to Sanofi's Fluzone Quadrivalent, a 4-1 influenza vaccine, and now the estimates on the revenue upside are starting to roll in. ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS